Fig. 6From: Development and external validation of a novel nomogram for predicting cancer-specific survival in patients with ascending colon adenocarcinoma after surgery: a population-based studyDecision curve analysis of 1-, 3- and 5-year CSS predicting the nomogram and TNM stage system in the internal validation (A, B and C) and external validation sets (D, E and F). The x-axis shows the threshold probabilities. The y-axis represents net benefit. The grey line indicates the assumption that all patients died from ascending colon adenocarcinoma. The black line indicates the assumption that all patients survivedBack to article page